{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:36:16Z","timestamp":1791329776124,"version":"4.3.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.revmed.2008.08.019","type":"journal-article","created":{"date-parts":[[2008,10,18]],"date-time":"2008-10-18T04:45:43Z","timestamp":1224305143000},"page":"287-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cellules souches m\u00e9senchymateuses et immunomodulation\u00a0: vers de nouvelles strat\u00e9gies immunosuppressives pour le traitement des maladies auto-immunes\u00a0?"],"prefix":"10.1016","volume":"30","author":[{"given":"J.","family":"Larghero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lecourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Verrecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Farge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2008.08.019_bib1","first-page":"267","article-title":"Fibroblast precursors in normal and irradiated mouse hematopoietic organs","volume":"4","author":"Friedenstein","year":"1976","journal-title":"Exp Hematol"},{"key":"10.1016\/j.revmed.2008.08.019_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.revmed.2008.08.019_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J Orthop Res"},{"key":"10.1016\/j.revmed.2008.08.019_bib4","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI28568","article-title":"The stem cell niches in bone","volume":"116","author":"Yin","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2008.08.019_bib5","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1073\/pnas.0402919101","article-title":"Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment","volume":"101","author":"Vosshenrich","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2008.08.019_bib6","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","article-title":"Interactions between human mesenchymal stem cells and natural killer cells","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.revmed.2008.08.019_bib9","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib10","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2008.08.019_bib11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1172\/JCI200420935","article-title":"Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation","volume":"113","author":"Dezawa","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2008.08.019_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/exnr.2000.7389","article-title":"Adult bone marrow stromal cells differentiate into neural cells in vitro","volume":"164","author":"Sanchez-Ramos","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.revmed.2008.08.019_bib13","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1172\/JCI0215182","article-title":"Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells","volume":"109","author":"Schwartz","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2008.08.019_bib14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI5298","article-title":"Cardiomyocytes can be generated from marrow stromal cells in vitro","volume":"103","author":"Makino","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2008.08.019_bib15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/labinvest.3700074","article-title":"Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes","volume":"84","author":"Oh","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.revmed.2008.08.019_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature00870","article-title":"Pluripotency of mesenchymal stem cells derived from adult marrow","volume":"418","author":"Jiang","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2008.08.019_bib17","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1242\/jcs.01103","article-title":"Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential","volume":"117","author":"D\u2019Ippolito","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.revmed.2008.08.019_bib18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/sj.leu.2404171","article-title":"A population of very small embryonic-like (VSEL) CXCR4+SSEA-1+Oct-4+ stem cells identified in adult bone marrow","volume":"20","author":"Kucia","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2008.08.019_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V78.1.55.55","article-title":"Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody STRO-1","volume":"78","author":"Simmons","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0301-472X(02)00812-3","article-title":"Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies","volume":"30","author":"Quirici","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.revmed.2008.08.019_bib21","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2007-07-099622","article-title":"Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells","volume":"111","author":"Delorme","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib22","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1182\/blood-2005-11-010504","article-title":"SSEA-4 identifies mesenchymal stem cells from bone marrow","volume":"109","author":"Gang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10735-007-9128-z","article-title":"Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells","volume":"38","author":"Rider","year":"2007","journal-title":"J Mol Histol"},{"key":"10.1016\/j.revmed.2008.08.019_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14653240310003611","article-title":"Immunomodulatory effects of fetal and adult mesenchymal stem cells","volume":"5","author":"Le Blanc","year":"2003","journal-title":"Cytotherapy"},{"key":"10.1016\/j.revmed.2008.08.019_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2008.08.019_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.revmed.2008.08.019_bib27","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","article-title":"Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide","volume":"101","author":"Krampera","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","article-title":"Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells","volume":"24","author":"Krampera","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.revmed.2008.08.019_bib29","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.exphem.2005.05.002","article-title":"Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells","volume":"33","author":"Groh","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.revmed.2008.08.019_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3727\/000000006780666957","article-title":"Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells","volume":"13","author":"Nasef","year":"2007","journal-title":"Gene Expr"},{"key":"10.1016\/j.revmed.2008.08.019_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","article-title":"Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G","volume":"84","author":"Nasef","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2008.08.019_bib32","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib33","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1182\/blood-2007-04-083162","article-title":"Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression","volume":"110","author":"Gieseke","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib34","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib35","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","article-title":"Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells","volume":"105","author":"Glennie","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib36","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","article-title":"Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals","volume":"102","author":"Djouad","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib37","first-page":"516","article-title":"Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory\/suppressive phenotype","volume":"90","author":"Maccario","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2008.08.019_bib38","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.revmed.2008.08.019_bib40","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/eji.200425405","article-title":"Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway","volume":"35","author":"Augello","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.revmed.2008.08.019_bib41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/dna.2005.24.458","article-title":"Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice","volume":"24","author":"Deng","year":"2005","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.revmed.2008.08.019_bib42","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2008.08.019_bib43","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib44","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/154732804323099190","article-title":"Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells","volume":"13","author":"Zhang","year":"2004","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.revmed.2008.08.019_bib46","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.177.4.2080","article-title":"Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells","volume":"177","author":"Nauta","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2008.08.019_bib47","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1634\/stemcells.2006-0548","article-title":"Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism","volume":"25","author":"Djouad","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.revmed.2008.08.019_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01.tp.0000244572.24780.54","article-title":"Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle","volume":"83","author":"Ramasamy","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2008.08.019_bib49","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1097\/00007890-199911150-00024","article-title":"Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment","volume":"68","author":"Gurevitch","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2008.08.019_bib50","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1097\/00007890-200006270-00006","article-title":"Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning","volume":"69","author":"Bingaman","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2008.08.019_bib51","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"108","author":"Nauta","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib52","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1634\/stemcells.2006-0228","article-title":"Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease","volume":"24","author":"Ya\u00f1ez","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.revmed.2008.08.019_bib53","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.4049\/jimmunol.176.12.7761","article-title":"Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice","volume":"176","author":"Sudres","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2008.08.019_bib54","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.1073\/pnas.84.21.7681","article-title":"Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation","volume":"84","author":"Anklesaria","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2008.08.019_bib55","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1182\/blood.V95.11.3620","article-title":"Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation","volume":"95","author":"Almeida-Porada","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0301-472X(00)00635-4","article-title":"Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion","volume":"29","author":"Devine","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.revmed.2008.08.019_bib57","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jgm.452","article-title":"Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome","volume":"5","author":"Chapel","year":"2003","journal-title":"J Gene Med"},{"key":"10.1016\/j.revmed.2008.08.019_bib58","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1182\/blood-2003-04-1121","article-title":"Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD\/SCID mouse and their role in supporting human CD34 cell engraftment","volume":"103","author":"Bensidhoum","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.it.2007.03.001","article-title":"Mesenchymal stem cells: a new strategy for immunosuppression?","volume":"28","author":"Uccelli","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.revmed.2008.08.019_bib60","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.21012","article-title":"Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis","volume":"52","author":"Djouad","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2008.08.019_bib61","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/art.22511","article-title":"Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis","volume":"56","author":"Augello","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2008.08.019_bib62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ana.21076","article-title":"Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis","volume":"61","author":"Gerdoni","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2008.08.019_bib63","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1634\/stemcells.19-3-226","article-title":"Crucial role of donor-derived stromal cells in successful treatment for intractable autoimmune diseases in MRL\/LPR mice by BMT via portal vein","volume":"19","author":"Kushida","year":"2001","journal-title":"Stem Cells"},{"key":"10.1016\/j.revmed.2008.08.019_bib64","doi-asserted-by":"crossref","first-page":"17438","DOI":"10.1073\/pnas.0608249103","article-title":"Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice","volume":"103","author":"Lee","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2008.08.019_bib65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2141.2001.03076.x","article-title":"Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus","volume":"115","author":"Papadaki","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2008.08.019_bib66","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood.V99.5.1610","article-title":"Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect","volume":"99","author":"Papadaki","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib67","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/sj.bmt.1705179","article-title":"Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis","volume":"36","author":"Papadaki","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2008.08.019_bib68","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/art.22035","article-title":"Bone marrow endothelial progenitors are defective in systemic sclerosis","volume":"54","author":"Del Papa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2008.08.019_bib69","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.22698","article-title":"Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis","volume":"56","author":"Cipriani","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2008.08.019_bib70","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/ard.2007.071233","article-title":"Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from systemic sclerosis patients","volume":"67","author":"Larghero","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2008.08.019_bib71","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/rheumatology\/kel267","article-title":"Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro","volume":"46","author":"Bocelli-Tyndall","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2008.08.019_bib72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar2128","article-title":"Cell therapy for autoimmune diseases","volume":"9","author":"Dazzi","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2008.08.019_bib73","first-page":"557","article-title":"Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use","volume":"16","author":"Lazarus","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2008.08.019_bib74","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Koc","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2008.08.019_bib75","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","article-title":"Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients","volume":"11","author":"Lazarus","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.revmed.2008.08.019_bib76","first-page":"75","article-title":"Expanded mesenchymal stem cells (MSC), co-infused with HLA identical hemopoietic stem cell transplants, reduce acute and chronic graft versus host disease: a matched pair analysis (abstract)","volume":"29","author":"Frassoni","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2008.08.019_bib77","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2007-04-087056","article-title":"Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation","volume":"110","author":"Ball","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib78","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.leu.2404550","article-title":"Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation","volume":"21","author":"Fouillard","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2008.08.019_bib79","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.leu.2402786","article-title":"Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma","volume":"17","author":"Fouillard","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2008.08.019_bib80","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2007.12.011","article-title":"A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases","volume":"30","author":"Ikehara","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2008.08.019_bib81","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringd\u00e9n","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2008.08.019_bib82","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2008.08.019_bib83","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.revmed.2008.08.019_bib84","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.leu.2405090","article-title":"The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study","volume":"22","author":"Ning","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2008.08.019_bib85","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.revmed.2008.08.019_bib86","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2008.08.019_bib87","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM200102013440516","article-title":"Repair of large bone defects with the use of autologous bone marrow stromal cells","volume":"344","author":"Quarto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2008.08.019_bib88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1703650","article-title":"Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)","volume":"30","author":"Koc","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2008.08.019_bib89","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.leu.2404996","article-title":"Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L","volume":"22","author":"Christopeit","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2008.08.019_bib90","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2006-01-0057","article-title":"Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma","volume":"107","author":"Chan","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib91","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2005-07-2793","article-title":"Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell","volume":"107","author":"Stagg","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib92","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","article-title":"Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice","volume":"106","author":"Eliopoulos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib93","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood-2002-06-1830","article-title":"Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates","volume":"101","author":"Devine","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.08.019_bib94","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1634\/stemcells.2005-0260","article-title":"Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage","volume":"24","author":"Fran\u00e7ois","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.revmed.2008.08.019_bib95","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/14653240500363216","article-title":"Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture","volume":"7","author":"Wang","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.revmed.2008.08.019_bib96","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1634\/stemcells.2005-0403","article-title":"Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation","volume":"24","author":"Miura","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.revmed.2008.08.019_bib97","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1634\/stemcells.2005-0620","article-title":"Sarcoma derived from cultured mesenchymal stem cells","volume":"25","author":"Tolar","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.revmed.2008.08.019_bib98","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1158\/0008-5472.CAN-04-4194","article-title":"Spontaneous human adult stem cell transformation","volume":"65","author":"Rubio","year":"2005","journal-title":"Cancer Res"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866308008321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866308008321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:24:36Z","timestamp":1759335876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866308008321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0248866308008321"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2008.08.019","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellules souches m\u00e9senchymateuses et immunomodulation\u00a0: vers de nouvelles strat\u00e9gies immunosuppressives pour le traitement des maladies auto-immunes\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2008.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}